New York, NY, June 14, 2006 – Ogilvy Public Relations Worldwide (Ogilvy PR) announced today that leading healthcare communicator, Michael Durand has joined the organization as a Managing Director. Michael will be a part of Strategy + Planning, the agency’s dedicated team of global senior counselors, where he will work closely with the firm’s leadership to drive growth with existing healthcare clients as well as participate in business development initiatives across healthcare and other practices worldwide.
“We are fortunate to have Michael join Ogilvy PR, as he is considered one of the best healthcare PR professionals in the business today,” said Marcia Silverman, global CEO. “Michael’s deep knowledge of the healthcare industry, his passion for public relations and his focus on leveraging integrated marketing communications, such as our 360 Degree Brand Stewardship® approach, to maximize message penetration, makes him the ideal fit for our organization. To that end, I am confident that he will be an integral part of the continued success of our healthcare practice.”
A seasoned industry veteran and specialist in biopharmaceutical marketing and health education, Michael has worked with a wide range of healthcare and pharmaceutical clients. He has managed the launch and ongoing public relations initiatives for many landmark drugs including Taxotere for Aventis, Diovan for Novartis and Vytorin for Merck/Schering Plough. Michael has also conducted corporate positioning and issues management programs for such companies as Amgen, Cephalon, Glaxo SmithKline and Bristol-Myers Squibb and has provided client counsel on regulatory affairs and in public affairs issues affecting the biotechnology industry. He is an accomplished author with numerous published articles on healthcare communications, pharmaceuticals marketing and international affairs.
“My decision to join Ogilvy PR was based on the agency’s rich history in healthcare and pharmaceuticals communications and strong pool of public relations talent,” Durand said. “Additionally, the opportunity to work with Strategy+Planning and to bring my experience and expertise to other practice areas across the agency is very exciting to me.”
Michael joins Ogilvy PR from Porter Novelli where he was a Partner and founder of its Health Care Practice. He was most recently senior counselor in the practice.
About Ogilvy Public Relations Worldwide
Ogilvy Public Relations Worldwide is a global marketing communications firm, with offices in more than 60 cities around the world. Entering its 25th year providing public relations solutions, Ogilvy Public Relations Worldwide has specialties in consumer marketing, corporate (B2B), healthcare, social marketing, technology, public affairs and entertainment. Through its subsidiary Feinstein Kean Healthcare, Ogilvy Public Relations Worldwide provides communication consulting to biotechnology companies. The Holmes Report has named Ogilvy Public Relations Worldwide “2003 International Agency of the Year”; marking the fourth consecutive year the firm has been awarded “Agency of the Year.” Ogilvy Public Relations Worldwide is part of the WPP Group, one of the world’s leading communications services groups (NASDAQ: WPPGY, www.wpp.com). For more information, visit our Web site at www.ogilvypr.com.